Case Studies / Commercial & Digital Health Strategy
Informing digital health strategy for R&D in immunology
Challenge
A top 3 biopharma company sought deep dive evaluation of digital therapeutic trends and emerging innovation across 13 immunology indications
The client requested an analysis of digital measures across immunology clinical trials and best practice considerations
Approach
Explored digital therapeutic competitive activity and benchmarked clinical validation, regulatory status & biopharma partnerships
Probed business model trends including overall shift from DTC to payer and employer coverage, evolving digital formularies and payer drivers and barriers
Evaluated pharma/digital health partnerships
Results
Our team synthesized implications for the client’s digital health strategy across immunology and by indication
Output was used to help sharpen immunology digital health strategy and launch several initiatives